Teyro Labs Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. A-9/1, SIPCOT Industrial Growth Centre Oragadam, Kanchipuram District, Tamil Nadu 601301, India (IND)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3021389808 · DUNS 854377573
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-11-12
Drugs this plant is listed as making
5 distinct drugs across 14 products name this site in their FDA label.
- capecitabineTeyro Labs Private Limited
- Carboplatinin shortageApotex Corp.
- Gemcitabine hydrochlorideTeyro Labs Private Limited
- pazopanib hydrochlorideNovugen Pharma (USA) LLC.
- Sunitinib MalateNovugen Pharma (USA) LLC.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.